Clinical Trials

Showing trials with last updates posted in 2025.

NCT06972147 | RECRUITING
40 Participants

Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-01
Completion: 2026-05-01
Conditions
Eosinophilic Esophagitis
No Results Yet
NCT06969287 | NOT_YET_RECRUITING | PHASE3
46 Participants

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-02-01
Completion: 2027-04-01
Conditions
Delirium Surgery-Complications
Interventions
DRUG
No Results Yet
NCT06968195 | SUSPENDED | PHASE1
24 Participants

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-01-30
Completion: 2028-05-30
Conditions
Advanced Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma Recurrent Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8
Interventions
BIOLOGICAL PROCEDURE DRUG
No Results Yet
NCT06966700 | RECRUITING | PHASE3
2400 Participants

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-30
Completion: 2033-03-23
Conditions
Breast Neoplasms Triple Negative Breast Neoplasms HR Low-Positive/HER2-Negative Breast Neoplasms
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06966323 | RECRUITING
150 Participants

Hold me Tight/Let me Go: Effectiveness of a Course to Enhance Parent-adolescent Relationship

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-11
Completion: 2028-02-01
Conditions
Parent Training Parent Child Relationship Parent-child Problem
Interventions
BEHAVIORAL
No Results Yet
NCT06962345 | COMPLETED | NA
80 Participants

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel (XCMIM20m) Assessed by PROMs.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-01-08
Completion: 2024-12-17
Conditions
Vulvar Atrophy Vulvovaginal Signs and Symptoms Genitourinary Syndrome of Menopause Quality of Life Menopause Related Conditions Dyspareunia Urinary Incontinence, Urgency-frequency Sexual Function Women´s Health Vaginal Dryness
Interventions
DEVICE
No Results Yet
NCT06962280 | RECRUITING | PHASE3
465 Participants

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-12
Completion: 2027-04-30
Conditions
Type 1 Diabetes Obesity Overweight
Interventions
DRUG
No Results Yet
NCT06952530 | RECRUITING | PHASE3
487 Participants

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-30
Completion: 2027-09-30
Conditions
Hypertension
Interventions
DRUG
No Results Yet
NCT06952504 | RECRUITING | PHASE3
1123 Participants

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-22
Completion: 2032-05-24
Conditions
Endometrial Cancer
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06948435 | RECRUITING | PHASE3
487 Participants

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-30
Completion: 2027-09-30
Conditions
Hypertension Overweight or Obesity
Interventions
DRUG
No Results Yet
NCT06945419 | RECRUITING | PHASE1
201 Participants

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-23
Completion: 2026-04-30
Conditions
Healthy Overweight Obesity Type 2 Diabetes
Interventions
DRUG
No Results Yet
NCT06944028 | RECRUITING | NA
666 Participants

Evaluation of Selective and Stepwise Excavation in Young Permanent Teeth With Deep Caries Lesions.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-09-01
Completion: 2028-09-01
Conditions
Dental Caries Dental Cavities
Interventions
PROCEDURE
No Results Yet
NCT06942832 | COMPLETED | NA
142 Participants

Integrating SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dementia

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-24
Completion: 2025-12-18
Conditions
Disease and Dysfunction Functional Fitness Deterioration Activities of Daily Living Instrumental Activities of Daily Living Sleep Quality
Interventions
OTHER
No Results Yet
NCT06942637 | ACTIVE_NOT_RECRUITING | NA
680 Participants

Effectiveness of Integrated Network for Student Psychosocial Intervention, Resilience, and Education (INSPIRE) on Mental Health Outcomes Among Indonesian Adolescents in Bandung

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-28
Completion: 2026-02-16
Conditions
Adolescents Health Knowledge Mental Health Health Literacy Resilience Depression Anxiety Parents School Intervention
Interventions
BEHAVIORAL
No Results Yet
NCT06941597 | COMPLETED
40 Participants

Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-28
Completion: 2025-10-05
Conditions
Cardiovascular Diseases (CVD) Coronary Heart Disease (CHD) Heart Failure Congenital Heart Disease
No Results Yet
NCT06941506 | COMPLETED | NA
142 Participants

Using SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dementia

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-23
Completion: 2025-12-18
Conditions
Cognitive and Behavioral Impairment Sensory and Perceptual Impairment
Interventions
OTHER
No Results Yet
NCT06941272 | RECRUITING | PHASE1/PHASE2
50 Participants

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-26
Completion: 2030-12-30
Conditions
Malignant Neoplasm
Interventions
BIOLOGICAL
No Results Yet
NCT06939686 | RECRUITING | NA
30 Participants

Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-11-01
Completion: 2026-07-31
Conditions
Diabetic Foot Ulcers (DFUs) Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer)
Interventions
DEVICE OTHER
No Results Yet
NCT06939673 | RECRUITING | NA
20 Participants

Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-02-29
Completion: 2025-12-31
Conditions
Diabetic Foot Ulcers (DFUs) Venous Leg Ulcers (VLUs) Pressure Ulcers Surgical Wound Dehiscence (SWD) Chronic Wounds Undermined and Tunneling Wounds
Interventions
DEVICE
No Results Yet
NCT06939647 | AVAILABLE

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Study Type: EXPANDED_ACCESS
Last Updated: 2025-12-24
Conditions
Pulmonary Arterial Hypertension Pulmonary Hypertension, Interstitial Lung Disease
Interventions
DRUG
No Results Yet
NCT06925737 | RECRUITING | PHASE3
1440 Participants

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-13
Completion: 2028-06-26
Conditions
Prostate Cancer Prostatic Neoplasms
Interventions
DRUG
No Results Yet
NCT06921824 | COMPLETED | NA
16 Participants

Investigating the Acute Effects of Increasing Glucagon Exposure in Healthy Participants

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-31
Completion: 2025-09-19
Conditions
Glucose Metabolism Glucagon
Interventions
OTHER
No Results Yet
NCT06920043 | RECRUITING | PHASE2
42 Participants

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-09
Completion: 2027-11-30
Conditions
Metabolic Dysfunction-Associated Steatohepatitis
Interventions
DRUG
No Results Yet
NCT06917313 | RECRUITING | PHASE2
92 Participants

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-12-05
Completion: 2028-03-31
Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
DRUG
No Results Yet
NCT06916806 | RECRUITING | PHASE1
72 Participants

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-01
Completion: 2027-06-22
Conditions
Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathies Rheumatoid Arthritis
Interventions
DRUG
No Results Yet
NCT06914895 | RECRUITING | PHASE3
905 Participants

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-25
Completion: 2027-05-31
Conditions
Type 1 Diabetes Obesity Overweight
Interventions
DRUG
No Results Yet
NCT06912633 | RECRUITING | PHASE2
60 Participants

Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-20
Completion: 2026-09-30
Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL OTHER
No Results Yet
NCT06909565 | RECRUITING | PHASE4
6000 Participants

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-23
Completion: 2029-10-31
Conditions
Percutaneous Coronary Intervention Peripheral Endovascular Intervention
Interventions
DRUG
No Results Yet
NCT06902558 | RECRUITING | PHASE2
240 Participants

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-06-09
Completion: 2029-08-31
Conditions
Autosomal Dominant Polycystic Kidney Disease
Interventions
DRUG
No Results Yet
NCT06901544 | COMPLETED
100 Participants

Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-04
Completion: 2025-08-01
Conditions
Intra-Abdominal Infections Intestinal Obstruction Appendicitis Acute Perforated Viscus
NCT06897475 | RECRUITING | PHASE2
240 Participants

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-28
Completion: 2026-12-31
Conditions
Type 2 Diabetes
Interventions
DRUG
No Results Yet
NCT06890884 | RECRUITING | PHASE2
594 Participants

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-11
Completion: 2027-12-13
Conditions
Lymphoma, Large B-Cell, Diffuse
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06881784 | RECRUITING | PHASE3
420 Participants

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-06
Completion: 2027-12-01
Conditions
NSCLC (Non-small Cell Lung Cancer) Non-Small Cell Lung Cancer NSCLC NSCLC (Non-small Cell Lung Carcinoma) NSCLC (Advanced Non-small Cell Lung Cancer)
Interventions
DRUG
No Results Yet
NCT06880055 | RECRUITING
3375 Participants

Shield Post-Approval Study Protocol

Study Type: OBSERVATIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-14
Completion: 2030-09-01
Conditions
Colo-rectal Cancer
Interventions
DIAGNOSTIC_TEST
No Results Yet
NCT06875115 | COMPLETED | NA
60 Participants

Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2024-04-09
Completion: 2024-05-11
Conditions
Uremia
Interventions
DEVICE
NCT06871410 | RECRUITING | PHASE1
26 Participants

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2026-01-15
Completion: 2028-04-01
Conditions
Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia
Interventions
DRUG PROCEDURE OTHER
No Results Yet
NCT06865651 | RECRUITING | PHASE2
44 Participants

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-05-22
Completion: 2027-09-01
Conditions
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Interventions
DRUG
No Results Yet
NCT06864104 | ACTIVE_NOT_RECRUITING | PHASE2
206 Participants

A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-04-10
Completion: 2026-01-09
Conditions
Hypertension
Interventions
DRUG
No Results Yet
NCT06864026 | RECRUITING | PHASE4
200 Participants

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-03-06
Completion: 2027-11-30
Conditions
Psoriatic Arthritis Overweight or Obesity
Interventions
DRUG
No Results Yet
NCT06863272 | RECRUITING | PHASE1/PHASE2
360 Participants

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Study Type: INTERVENTIONAL
Last Updated: 2025-12-24
Start Date: 2025-07-03
Completion: 2030-02-18
Conditions
Castration-Resistant Prostatic Cancer Metastasis
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page